Hsbc Holdings PLC Meridian Bioscience Inc Transaction History

Hsbc Holdings PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $1.07 Million - $1.14 Million	34,250 Added 8.41%	441,656 $14.7 Million
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $12.2 Million - $13.3 Million	395,886 Added 3436.51%	407,406 $12.9 Million
Q2 2022 Aug 11, 2022	SELL	$23.75 - $31.69 $23,156 - $30,897	-975 Reduced 7.8%	11,520 $353,000
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $249,525 - $336,615	12,495 New	12,495 $332,000
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $374,768 - $566,893	-18,966 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$15.73 - $21.66 $98,658 - $135,851	-6,272 Reduced 24.85%	18,966 $354,000
Q3 2020 Nov 12, 2020	BUY	$13.54 - $26.41 $341,722 - $666,535	25,238 New	25,238 $426,000
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $838,610 - $952,155	-54,069 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$14.52 - $19.72 $785,081 - $1.07 Million	54,069 New	54,069 $939,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.